Background Glioblastoma multiforme (GBM) is the most common cancer of the central
nervous system, while Parkinson's disease (PD) is a degenerative neurological condition …

Alzheimer's disease (AD) is one of the most common causes of dementia. Despite several
decades of research in AD, there is no standard disease-modifying therapy available and …

The available treatments for patients affected by Alzheimer's disease (AD) are not curative.
Numerous clinical trials have failed during the past decades. Therefore, scientists need to …

Alzheimer's disease (AD) animal studies have reported that mesenchymal stem cells
(MSCs) have therapeutic effects; however, clinical trial results are controversial. Neprilysin …

Dental pulp stem cells are dental pulp-derived mesenchymal stem cells that originate from
the neural crest. They exhibit greater potential for the treatment of nervous system diseases …

Alzheimer's disease (AD) is a common disorder characterized by aggregation and
conversion of amyloid beta (Aβ) monomers to fibrils. Betulinic acid (BA) strongly accelerated …

Background Alzheimer's disease (AD) is a globally prevalent neurodegenerative disease,
clinically characterized by progressive memory loss and gradual impairment of cognitive …

Background Alzheimer's disease (AD) is a neurodegenerative disorder presenting cognitive
decline accompanied by deposits of amyloid-β (Aβ) and tau hyperphosphorylation. Without …

Alzheimer's disease (AD) is one of the untreatable neurodegenerative disorders with
associated societal burden. Current therapies only provide symptomatic relief without …

Stroke is the leading cause of severe disability, and lacunar stroke is related to cognitive
decline and hemiparesis. There is no effective treatment for the majority of patients with …